Statistics
Total Visits
| Views | |
|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 68 |
Total Visits per Month
| March 2023 | April 2023 | May 2023 | June 2023 | July 2023 | August 2023 | September 2023 | |
|---|---|---|---|---|---|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 1 | 0 | 0 | 1 | 0 | 2 | 2 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 48 |
| Germany | 9 |
| China | 5 |
| Czech Republic | 1 |
| Russia | 1 |
| Ukraine | 1 |
| Vietnam | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 16 |
| Fairfield | 7 |
| Ann Arbor | 4 |
| Des Moines | 4 |
| San Diego | 3 |
| Dearborn | 2 |
| Shenzhen | 2 |
| Cambridge | 1 |
| Clover | 1 |
| Hanoi | 1 |